Clinical Trials Logo

Congenital Hip Dislocation clinical trials

View clinical trials related to Congenital Hip Dislocation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04212832 Completed - Clinical trials for Congenital Hip Dislocation

Quadratus Lumborum Block for Congenital Hip Dislocation Surgery

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

Developmental dysplasia of the hip (DDH) is one of the major disorder of the pediatric population with an incidence of 3 to 5 per 1000 children. Open surgical reduction of congenital hip dislocation (CHD) is typically performed after an ineffective closed reduction or older than 18 months. Multiple femoral or pelvic osteotomies and tenotomies are performed during this surgical treatment and cause severe postoperative pain.Since initial description for abdominal surgery, the quadratus lumborum block has experienced several surgeries for postoperative pain management in adults and pediatrics. One of these indication is the hip surgery and described for adult hip arthroplasty. In addition we reported two pediatric cases that single dose transmuscular quadratus lumborum block is an affective analgesia for CHD surgery. The aim of this study was to evaluate the analgesic effect of ultrasound guided transmuscular quadratus lumborum block in pediatric patients undergoing CHD surgery.

NCT ID: NCT02900482 Completed - Clinical trials for Congenital Hip Dislocation

Research for Genetic Factors Involved in Congenital Dislocation of Hip: Genome-wide Association Study in Grand West France

GENETHIP
Start date: November 23, 2012
Phase:
Study type: Observational

The main objective is to identify the genes involved in congenital dislocation of the hip. The secondary objectives are to measure the association between mechanical risk factors and congenital dislocation of hip and study the interactions between these factors and genetic factors.